Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency
- 7 July 1984
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 57 (3) , 527-537
- https://doi.org/10.1111/j.1365-2141.1984.tb02927.x
Abstract
Three patients with familial antithrombin III deficiency underwent a trial of prophylactic antithrombotic therapy with stanozolol. An increase in plasma fibrinolytic activity and antithrombin III was seen. Acute venous thrombosis occurred in 2 patients; in the 1st patient thrombosis was precipitated by venography but in the 2nd no precipitating factor was found. Stanozolol possibly is not a suitable prophylactic agent in patients with familial antithrombin III deficiency.This publication has 13 references indexed in Scilit:
- Transfusion Studies in Patients with Familial Antithrombin III (ATIII) Deficiency: Half‐disappearance Time of Infused ATIII and Influence of such Infusion on Platelet Life‐spanBritish Journal of Haematology, 1981
- The fibrinolytic response to stanozolol in normal subjectsThrombosis Research, 1981
- Prevalence of coronary heart disease in the framingham offspring study: Role of lipoprotein cholesterolsThe American Journal of Cardiology, 1980
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Effect of ethyloestrenol on fibrinolysis in the vessel wall.BMJ, 1976
- Two Progressive Inhibitors of Factor Xa in Human BloodBritish Journal of Haematology, 1972
- Comparison of Progressive Antithrombin Activity and the Concentrations of Three Thrombin Inhibitors in Human PlasmaScandinavian Journal of Clinical and Laboratory Investigation, 1970
- Plasma fibrinogen and plasminogen levels in health and in ischaemic heart diseaseJournal of Clinical Pathology, 1966
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955
- The fibrin plate method for estimating fibrinolytic activityArchives of Biochemistry and Biophysics, 1952